Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

2.
3.
4.

Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.

Taylor JE, Peat N, Porter C, Morgan AG.

Nephrol Dial Transplant. 1996 Jun;11(6):1079-83.

5.
8.

Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.

Bárány P, Clyne N, Hylander B, Johansson AC, Simonsen O, Larsson R, Frisenette-Fich C, Svensson B, Helmers C.

Perit Dial Int. 1995;15(1):54-60.

9.

A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.

Van Damme-Lombaerts R, Broyer M, Businger J, Baldauf C, Stocker H.

Pediatr Nephrol. 1994 Jun;8(3):338-42.

PMID:
7917862
10.

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.

Am Heart J. 2006 Dec;152(6):1096.e9-15.

PMID:
17161060
11.

Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction.

Muirhead N, Cattran DC, Zaltzman J, Jindal K, First MR, Boucher A, Keown PA, Munch LC, Wong C.

J Am Soc Nephrol. 1994 Nov;5(5):1216-22.

12.

Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis.

Harris DC, Chapman JR, Stewart JH, Lawrence S, Roger SD.

Aust N Z J Med. 1991 Oct;21(5):693-700.

PMID:
1759917
13.

Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.

Stevens ME, Summerfield GP, Hall AA, Beck CA, Harding AJ, Cove-Smith JR, Paterson AD.

BMJ. 1992 Feb 22;304(6825):474-7.

14.

Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.

Bárány P, Pettersson E, Konarski-Svensson JK.

Nephrol Dial Transplant. 1993;8(5):426-32.

PMID:
8393547
15.

Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.

Teruel JL, Aguilera A, Marcen R, Navarro Antolin J, Garcia Otero G, Ortuño J.

Scand J Urol Nephrol. 1996 Oct;30(5):403-8.

PMID:
8936631
16.

The quality of life of dialysis patients treated with recombinant human erythropoietin.

Auer J, Oliver DO, Winearls CG.

Scand J Urol Nephrol Suppl. 1990;131:61-5.

PMID:
2075472
17.

Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.

Gasché C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H.

Ann Intern Med. 1997 May 15;126(10):782-7.

PMID:
9148651
18.

Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.

Keown PA, Churchill DN, Poulin-Costello M, Lei L, Gantotti S, Agodoa I, Gitlin M, Gandra SR, Mayne TJ.

Hemodial Int. 2010 Apr;14(2):168-73. doi: 10.1111/j.1542-4758.2009.00422.x. Epub 2010 Mar 24.

PMID:
20345390
19.

Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.

Zehnder C, Glück Z, Descoeudres C, Uehlinger DE, Blumberg A.

Nephrol Dial Transplant. 1988;3(5):657-60.

PMID:
3146724
Items per page

Supplemental Content

Write to the Help Desk